Dark Canyon Laboratories Revenue
Pharmaceutical Manufacturing • 
Rapid City, South Dakota, United States • 1-10 Employees
Dark Canyon Laboratories revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Dark Canyon Laboratories
Vera Kowal
Chief Executive Officer
Company overview
| Headquarters | 402 St. Joseph St., Ste. 17, Rapid City, SD 57702, US |
| Website | |
| NAICS | 3254 |
| SIC | 807 |
| Keywords | R&D, Clinical Trial Development, Colonoscopy Preparation Development |
| Founded | 2009 |
| Employees | 1-10 |
Dark Canyon Laboratories Email Formats
Dark Canyon Laboratories uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@darkcanyonlabs.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@darkcanyonlabs.com | 66.7% |
{first initial}.{last name} | j.doe@darkcanyonlabs.com | 33.3% |
About Dark Canyon Laboratories
Dark Canyon Labs is a virtual company based in Rapid City, South Dakota, and founded by physicians Dale Bachwich, MD and Vera Kowal, MD. Dark Canyon Labs is dedicated to improving the colonoscopy prep experience for all patients. Colon and rectal cancers kill 50,000 patients each year in the US. That’s like a jet plane crashing every day. Studies show that colon cancer is affecting people at a younger age than in the past. Recently, the recommended initial screening age was lowered to 45. Colonoscopy screening is a very effective way to reduce the number of new cancer cases, yet only 60% of eligible patients get screened. Part of the reluctance to get screened has been due to the existing prep process...horrible-tasting preps in large volumes. DCL-101 is a new patented colonoscopy Pill Prep developed by Dark Canyon Labs that aims to provide a good experience for patients preparing for their colonoscopy procedure. A safe, good-tasting prep means better patient compliance, which leads to better quality preps, higher polyp detection rates, and saved lives. A multicenter, randomized, investigator-blinded, non-inferiority Phase 2 Clinical Trial was completed in June 2018. The trial is listed on www.ClinicalTrials.gov, a service of the National Institutes of Health. Plans for two definitive Phase 3 Trials are underway.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Dark Canyon Laboratories has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Dark Canyon Laboratories has never raised funding before.
Dark Canyon Laboratories Tech Stack
Discover the technologies and tools that power Dark Canyon Laboratories's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Security
Ecommerce
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
Video players
Maps
Germany
Lebanon
Canada
Lithuania
AustraliaFrequently asked questions
4.8
40,000 users
